Literature DB >> 10027839

Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats.

H L Pan1, J C Eisenach, S R Chen.   

Abstract

Repetitive ectopic discharges from injured afferent nerves play an important role in initiation and maintenance of neuropathic pain. Gabapentin is effective for treatment of neuropathic pain but the sites and mechanisms of its antinociceptive actions remain uncertain. In the present study, we tested a hypothesis that therapeutic doses of gabapentin suppress ectopic afferent discharge activity generated from injured peripheral nerves. Mechanical allodynia, induced by partial ligation of the sciatic nerve in rats, was determined by application of von Frey filaments to the hindpaw. Single-unit afferent nerve activity was recorded proximal to the ligated sciatic nerve site. Intravenous gabapentin, in a range of 30 to 90 mg/kg, significantly attenuated allodynia in nerve-injured rats. Furthermore, gabapentin, in the same therapeutic dose range, dose-dependently inhibited the ectopic discharge activity of 15 injured sciatic afferent nerve fibers through an action on impulse generation. However, the conduction velocity and responses of 12 normal afferent fibers to mechanical stimulation were not affected by gabapentin. Therefore, this study provides electrophysiological evidence that gabapentin is capable of suppressing the ectopic discharge activity from injured peripheral nerves. This action may contribute, at least in part, to the antiallodynic effect of gabapentin on neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027839

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

Review 1.  Ectopic discharge in Abeta afferents as a source of neuropathic pain.

Authors:  Marshall Devor
Journal:  Exp Brain Res       Date:  2009-02-26       Impact factor: 1.972

2.  Neurophysiology of Cancer Pain: From the Laboratory to the Clinic.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

3.  The combined analgesic effect of gabapentin and transdermal fentanyl patch on acute and chronic pain after maxillary cancer surgeries.

Authors:  Satish Dhasmana; Vibha Singh; U S Pal
Journal:  J Maxillofac Oral Surg       Date:  2009-06-10

4.  Bursting activity in myelinated sensory neurons plays a key role in pain behavior induced by localized inflammation of the rat sensory ganglion.

Authors:  W Xie; J A Strong; D Kim; S Shahrestani; J-M Zhang
Journal:  Neuroscience       Date:  2012-01-11       Impact factor: 3.590

5.  Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.

Authors:  Keiko Takasu; Motoko Honda; Hideki Ono; Mitsuo Tanabe
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 6.  Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity.

Authors:  Dimitris N Xanthos; Jürgen Sandkühler
Journal:  Nat Rev Neurosci       Date:  2013-11-27       Impact factor: 34.870

7.  Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats.

Authors:  Slobodan M Todorovic; A J Rastogi; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

8.  Effect of Gabapentin and Pregabalin in Rat Model of Taxol Induced Neuropathic Pain.

Authors:  A Mangaiarkkarasi; S Rameshkannan; R Meher Ali
Journal:  J Clin Diagn Res       Date:  2015-05-01

9.  Multiplicative interactions to enhance gabapentin to treat neuropathic pain.

Authors:  Ken-Ichiro Hayashida; James C Eisenach
Journal:  Eur J Pharmacol       Date:  2008-09-17       Impact factor: 4.432

10.  Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury.

Authors:  Marc R Suter; Temugin Berta; Yong-Jing Gao; Isabelle Decosterd; Ru-Rong Ji
Journal:  Mol Pain       Date:  2009-09-22       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.